Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema: Lessons Learned from Registration Trials

INTRODUCTION: This review aims to assess the efficacy, durability and safety of faricimab—a dual vascular endothelial growth factor and angiopoietin 2 inhibitor—in patients with neovascular age-related macular degeneration (nAMD) and diabetic macula oedema (DMO). It summarises the findings of curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Helene O., Grauslund, Jakob, Vergmann, Anna S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441964/
https://www.ncbi.nlm.nih.gov/pubmed/37410309
http://dx.doi.org/10.1007/s40123-023-00753-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441964/
https://www.ncbi.nlm.nih.gov/pubmed/37410309
http://dx.doi.org/10.1007/s40123-023-00753-6

Ejemplares similares